Analyst Ratings for Corcept Therapeutics (CORT) [Sells]
CORT Rating Summary
CORT Price Target Summary
- Highest: $42.00 (Truist Securities)
- Lowest: $35.00 (Piper Sandler)
- Average: $38.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$38.25 (+72.2%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
Avg. $ Target:
$38.25 (+72.2%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/20/2016 | Janney | N/A | New Coverage | Sell (N/A) |
7.00 (N/A) |
8.47 (22.21) |
162.22% | Details |
| 7/13/2012 | BofA Securities » Updated 7/6/2018 |
N/A | New Coverage | Underperform (N/A) |
6.00 (N/A) |
4.44 (22.21) |
400.23% | Details |
